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Abstract
Introduction:  For  the  treatment  of  rhinosinusitis  antibiotics  are  used  frequently.  Concerns  have
been raised  regarding  the  adverse  effects  of  antibiotics  and  growing  resistance.  The  lack  of
discovery of  new  antibiotic  compounds  has  increased  the  necessity  for  exploration  of  non-
antibiotic  compounds  that  have  antibacterial  activity.  Amlodipine  is  a  non-antibiotic  compound
with anti-inﬂammatory  activity.
Objective:  In  this  study  we  aimed  to  investigate  the  potential  role  of  amlodipine  in  treat-
ment of  rhinosinusitis  by  evaluating  its  effects  on  tissue  oxidative  status,  mucosal  histology  and
inﬂammation.
Methods: Fifteen  adult  albino  guinea  pigs  were  inoculated  with  Staphylococcus  aureus  and
treated with  saline,  cefazolin  sodium,  or  amlodipine  for  7  days.  The  control  group  was  ﬁve
healthy guinea  pigs.  Animals  were  sacriﬁced  after  the  treatment.  Histopathological  changes
were identiﬁed  using  Hematoxylin-Eosin  staining.  Inﬂammation  was  assessed  by  Polymorphonu-
clear Leukocyte  (PMNL)  inﬁltration  density.  Tissue  levels  of  antioxidants  (superoxide  dismutase,
glutathione)  and  an  oxidative  product  (malondialdehyde)  were  determined.
Results:  In  rhinosinusitis  induced  animals,  amlodipine  reduced  loss  of  cilia,  lamina  propria
edema and  collagen  deposition  compared  to  placebo  (saline)  and  although  not  superior  to
cefazolin, amlodipine  decreased  PMNL  inﬁltration.  The  superoxide  dismutase  activity  and  glu-
tathione levels  were  reduced,  whereas  the  malondialdehyde  levels  were  increased  signiﬁcantly Please cite this article as: Tatar A, Korkmaz M, Yayla M, Polat E, Uslu H, Halici Z, et al. The potential role of amlodipine on experimentally
induced bacterial rhinosinusitis. Braz J Otorhinolaryngol. 2016. http://dx.doi.org/10.1016/j.bjorl.2016.08.006
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in  all  three-treatment  groups  compared  to  the  control  group.  Amlodipine  treated  group  showed
signiﬁcantly  increased  superoxide  dismutase  and  glutathione  levels  and  decreased  malondialde-
hyde levels  compared  to  all  treatment  groups.
Conclusion:  The  non-antibiotic  compound  amlodipine  may  have  a  role  in  acute  rhinosinusitis
treatment  through  tissue  protective,  antioxidant  and  anti-inﬂammatory  mechanisms.
© 2016  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Published
by Elsevier  Editora  Ltda.  This  is  an  open  access  article  under  the  CC  BY  license  (http://
creativecommons.org/licenses/by/4.0/).
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O  papel  potencial  da  amlodipina  na  rinossinusite  bacteriana  induzida
experimentalmente
Resumo
Introduc¸ão:  Antibióticos  são  frequentemente  utilizados  para  o  tratamento  de  rinossinusite.
Questões têm  sido  levantadas  sobre  os  efeitos  adversos  dos  antibióticos  e  a  resistência  cres-
cente. A  falta  de  descoberta  de  novos  compostos  antibióticos  aumentou  a  necessidade  da
explorac¸ão de  compostos  não-antibióticos  que  possuem  atividade  antibacteriana.  A  amlodipina
é um  composto  não-antibiótico  com  atividade  anti-inﬂamatória.
Objetivo:  O  objetivo  desse  estudo  foi  investigar  o  papel  potencial  da  amlodipina  no  tratamento
da rinossinusite,  avaliando  seus  efeitos  sobre  o  estado  oxidativo  do  tecido,  histologia  da  mucosa
e inﬂamac¸ão.
Método:  Quinze  cobaias  albinas  adultas  foram  inoculadas  com  Staphylococcus  aureus  e  tratadas
com soluc¸ão  salina,  cefazolina,  ou  amlodipina  durante  7  dias.  O  grupo  controle  incluiu  cinco
cobaias saudáveis.  Os  animais  foram  sacriﬁcados  após  o  tratamento.  Alterac¸ões  histopatológicas
foram identiﬁcadas  utilizando-se  a  colorac¸ão  de  Hematoxilina-Eosina.  A  inﬂamac¸ão  foi  avaliada
pela densidade  de  inﬁltrac¸ão  de  leucócitos  polimorfonucleares  (LPMN).  Foram  determinados  os
níveis teciduais  de  antioxidantes  (superóxido  dismutase,  glutationa)  e  um  produto  de  oxidac¸ão
(malondialdeído).
Resultados:  Em  animais  com  rinossinusite  induzida,  a  amlodipina  reduziu  a  perda  dos  cílios,
edema da  lâmina  própria  e  deposic¸ão  de  colágeno  em  comparac¸ão  com  o  grupo  placebo  (soluc¸ão
salina) e  embora  não  seja  superior  à  cefazolina,  a  amlodipina  diminuiu  a  inﬁltrac¸ão  de  LPMN.
Os níveis  de  atividade  da  superóxido  dismutase  e  glutationa  foram  reduzidos,  enquanto  os
níveis de  malondialdeído  foram  signiﬁcativamente  aumentados  nos  três  grupos  de  tratamento
em comparac¸ão  com  o  grupo  controle.  O  grupo  tratado  com  amlodipina  apresentou  aumento
signiﬁcativo  dos  níveis  de  superóxido  dismutase  e  glutationa  e  diminuic¸ão  dos  níveis  de  malon-
dialdeído em  comparac¸ão  com  todos  os  grupos  de  tratamento.
Conclusão:  O  composto  não-antibiótico  amlodipina  pode  ter  um  papel  no  tratamento  da  rinoss-
inusite aguda  através  de  mecanismos  protetores  de  tecido,  antioxidantes  e  anti-inﬂamatórios.
© 2016  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Publicado
por Elsevier  Editora  Ltda.  Este e´  um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY  (http://
creativecommons.org/licenses/by/4.0/).
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hinosinusitis  is  characterized  by  inﬂammation  of  the
inus  and  nasal  mucosa.  It  is  one  of  the  most  common
ealth  problems  and  accounts  for  more  outpatient  antibi-
tic  prescriptions  than  any  other  diagnosis.1 Both  host
nd  environmental  factors  play  a  role  in  the  develop-
ent  of  rhinosinusitis.  The  pathophysiology  causing  acute
hinosinusitis  involves  a  series  of  changes  that  lead  to
bstruction  of  the  sinus  ostia,  swelling  and  inﬂammation
f  the  mucosa,  mucous  stasis,  impaired  mucociliary  clear-
nce,  and  microbial  infection.  The  goals  of  treatment
re  to  reduce  inﬂammation,  eradicate  infection,  improve
rainage  and  aeration  of  nasal  and  sinus  mucosa,  and  restore
a
r
iucociliary  function.2 Common  medical  therapies  for  acute
hinosinusitis  include  antibiotics,  nasal  saline  irrigation,
econgestants,  antihistamines,  mucolytics,  topical  or  sys-
emic  corticosteroids,  and  anti-inﬂammatory  drugs.  Little
vidence  supports  the  use  of  decongestants  and  antihis-
amines,  although  they  may  help  to  reduce  rhinorrhoea  and
asal  congestion.  Nasal  irrigation  with  saline  is  usually  used
n  acute  rhinosinusitis  and  may  improve  mucociliary  clear-
nce  but  evidence  is  limited  to  support  its  use.3,4
Antibiotics  are  commonly  prescribed  for  treatment  and
heir  use  has  been  suggested  to  shorten  the  time  to  cure
cute  bacterial  rhinosinusitis;  however,  concerns  have  been
aised  regarding  the  adverse  effects  of  antibiotics,  includ-
ng  resistance.  A  meta-analysis  of  randomized  controlled
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The  effect  of  amlodipine  on  rhinosinusitis  
trials  showed  that  use  of  antibiotics  for  acute  rhinosinusi-
tis  offers  a  small  therapeutic  beneﬁt  over  placebo,  with  a
corresponding  rise  in  the  risk  for  adverse  events.5
Reactive  Oxygen  Species  (ROS)  are  produced  under  phys-
iological  conditions  and  their  production  and  antioxidant
activity  are  balanced.  Excessive  accumulation  of  ROS  causes
lipid  and  protein  peroxidation  and  can  lead  to  cell  dam-
age  and  death.  Cells  overcome  this  oxidative  stress  via
anti-oxidant  defence  mechanisms  that  include  Superoxide
Dismutase  (SOD),  Glutathione  Peroxidase  (GPx),  Catalase
(CAT),  Glutathione  (GSH),  and  peroxiredoxins.  Malondialde-
hyde  (MDA),  a  product  of  lipid  peroxidation,  is  therefore  a
good  indicator  of  cellular  damage.  Recent  studies  showed
that  ROS  acts  as  second  messengers  for  inﬂammation  acti-
vation  and  play  a  role  in  inﬂammation.6,7
Amlodipine  (AML)  is  a  dihydropyridine  L-type  cal-
cium  channel  blocker  with  signiﬁcant  antibacterial  activity
against  several  gram-positive  and  gram-negative  strains.
It  is  reportedly  the  most  powerful  of  the  cardiovascu-
lar  drugs  with  antibacterial  activity.8,9 AML  also  has  been
reported  to  have  anti-inﬂammatory  activity.  AML  has  been
shown  to  decrease  ischemia-reperfusion  injury  by  improving
the  oxidative  status  in  ileum  ischemia-reperfusion  induced
rabbits.10
The  growth  of  antibiotic  resistance  and  the  lack  of  dis-
covery  of  new  antibiotic  compounds  have  increased  the
necessity  for  exploration  of  non-antibiotic  compounds  like
AML  that  have  antibacterial  activity.  In  both  acute  and
chronic  sinusitis,  inﬂammation  and  edema  leads  to  obstruc-
tion  of  sinus  ostia  that  further  exacerbates  the  disease.  We
suppose  that  anti-inﬂammatory  and  antibacterial  effects  of
AML  can  be  beneﬁcial  in  the  treatment  of  rhinosinusitis.
The  aim  of  the  present  study  was  to  investigate  possible
effects  of  AML  on  oxidative  status,  inﬂammation,  and  tis-
sue  integrity  in  an  animal  model  of  experimentally  induced
acute  rhinosinusitis.
Methods
Animals
Twenty  adult  albino  guinea  pigs  with  no  evidence  of  upper
respiratory  tract  infections  were  used.  Each  animal  weighed
330--370  g,  and  all  were  obtained  from  Ataturk  Univer-
sity’s  Experimental  Animal  Laboratory  at  the  Medicinal  and
Experimental  Application  and  Research  Centre.  The  animal
experiments  and  procedures  were  performed  in  accordance
with  national  guidelines  for  the  use  and  care  of  laboratory
animals,  and  the  study  was  approved  by  Ataturk  Univer-
sity’s  local  animal  care  committee  (approval  n◦ 2014-1/12).
The  guinea  pigs  were  housed  in  standard  plastic  cages  on
sawdust  bedding  in  an  air-conditioned  room  at  22◦ ±  1 ◦C
and  a  12:12  h  dark:light  cycle.  Standard  guinea  pig  food
and  tap  water  were  given  ad  libitum.  The  adaptation  time
before  the  experiment  was  2  weeks.  The  animals  were  ran-
domly  divided  into  four  groups  (ﬁve  animals  per  group):
one  group  served  as  a  negative  control  (Group  C;  no  rhi-
nosinusitis  induced,  only  treated  with  Intraperitoneal  [IP]
saline  injections),  one  group  had  rhinosinusitis  but  was  only
treated  with  IP  saline  injections  (Group  S;  positive  con-
trol),  one  group  had  rhinosinusitis  and  was  treated  with  oral
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mlodipine  (Group  SA),  and  one  group  had  rhinosinusitis  was
reated  with  cefazolin  (Group  SC).  Animals  were  sacriﬁced
t  7  days.
evelopment  of  the  animal  model
erocel  (Medtronic  Xomed,  Jacksonville,  FL,  USA)  was  cut
ith  microforceps.  Microscissors  were  used  to  shape  and
nsert  a  sponge  into  the  nostrils.  All  ﬁve  animals  in  the  S,
C,  and  SA  groups,  but  not  the  C  group,  were  administered
etamine  (i.m.,  50  mg/kg;  Ketalar  Pﬁzer,  Istanbul,  Turkey)
nd  diazepam  (i.m.,  2  mg/kg;  Diazem,  Deva,  Istanbul,
urkey).  The  nasal  dorsum  was  sterilized  with  povidone-
odine  and  gelatin  sponges  were  inserted  into  the  right
asal  cavities.  The  nostrils  were  then  inoculated  with
taphylococcus  aureus  (0.5  mL)  using  a  hypodermic  syringe
Staphylococcus  aureus  strain  ATCC  25923  was  suspended
ta  concentration  of  900  ×  106 CFU  [Colony-forming  units]
er  mL).  At  24  h  after  the  bacterial  inoculation,  the  Merocel
as  removed  from  the  nasal  cavities.  Purulent  nasal  secret-
ons  were  observed  in  the  nasal  cavities  of  animals.
Guinea  pigs  were  treated  twice  daily  for  a  7  days  with
njection  of  saline  IP  in  Group  S  and  Group  C  and  cefa-
olin  sodium  (i.m.,  50  mg/kg/day)  in  group  SC.  Group  SA
as  treated  with  per  oral  amlodipine  5  mg/kg/day  (dis-
olved  in  saline,  twice  daily)  for  7  days.  The  animals  were
hen  sacriﬁced  with  a  lethal  dose  of  thiopental  sodium  and
ecapitated.  The  external  nasal  dorsum  was  sterilized  with
ovidone-iodine  swab,  and  after  skin  elevation,  the  lateral
asal  walls  and  maxillary  sinuses  were  removed  from  the
ight  nasal  cavity.  The  mucosae  of  the  lateral  nasal  walls
ere  stored  at  −80 ◦C  for  biochemical  analysis.
istopathological  analysis
he  specimens  of  all  guinea  pig  were  rapidly  ﬁxed  in  10%
uffered  formalin  for  24  h  for  histological  examination.  After
he  ﬁxation,  tissue  samples  were  routinely  processed  and
mbedded  in  parafﬁn  wax  from  that  5  m-thick  sections
ere  cut.  Then,  six  sections  were  obtained  for  each  guinea
ig  tissue  and  placed  onto  positively  charged  slides.  The  sec-
ions  were  stained  with  Mayer’s  Hematoxylin  &  Eosin  after
he  deparafﬁnization  and  rehydration  of  them.  Later,  all
ections  were  examined  and  photographed  under  a  light
hotomicroscope  (Nikon  Eclipse  E600,  Japan)  for  histopatho-
ogical  examination.
emi-quantitative  analysis
he  50  m2 area  was  distinguished  by  means  of  a  m  slide
or  the  40×  magniﬁcation  for  each  section.  Histopathologi-
al  changes  in  the  parenchyma  and  stroma  parts  of  tissues
ere  determined  at  40×  objective  in  10  randomly  cho-
en  microscopic  areas  by  blinded  examiner.  Afterwards,
he  arithmetic  mean  was  semi-quantitatively  scored  as
ntroduced  by  Simsek  and  colleagues.11 Lamina  propria
dema,  ciliary  loss,  vasodilatation,  goblet  cell  number,  and
ollagen  deposition  were  scored.  The  scoring  was  deter-
ined  and  graded  as  absent  =  0,  mild  =  1,  moderate  =  2,  or
arked  =  3.12
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Group C Group S
Group SC Group SA
V
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Figure  1  Micrograph  of  tissues  for  all  groups.  E,  Epithelium;  LP,  Lamina  Propria;  V,  Vasodilatations  in  veins,  yellow  star;  goblet
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tereological  analysis
tereological  analyses  were  made  using  a  stereology  work-
tation  consisting  of  stereology  software  (Stereo  Investigator
ersion  9.0,  Microbrightﬁeld,  Colchester,  VT,  USA),  a  mod-
ﬁed  light  microscope  (Leica  DM4000  B,  Germany)  and  a
otorized  system  which  can  move  the  section  in  both  x  and  y
irection.  The  optic  fractionator  frame  method  was  used  to
ount  Polymorphonuclear  Leukocytes  (PMNLs)  in  the  lamina
ropria  of  six  tissue  sections  for  each  guinea  pig.  The  sec-
ions  were  examined  under  a  40×  Leica  Plan  Apo  objective
NA  =  1.40).  The  density  of  PMNLs  was  estimated  according
o  deﬁned  by  Kara  and  colleagues.13
iochemical  analysis
ateral  nasal  wall  mucosa  samples  sized  0.5  cm2 were
sed  for  biochemical  analysis.  Superoxide  Dismutase  (SOD)
ctivity,14 Glutathione  (GSH)15 levels,  and  Malondialdehyde
MDA)16 levels  were  determined  in  duplicate  for  each  sam-
le  supernatant  and  standards  at  room  temperature  using
 modiﬁed  method  and  an  ELISA  reader.  The  average
bsorbance  of  each  sample  and  standard  were  calculated.
 standard  curve  was  plotted  and  the  linear  relationship
quation  was  obtained  from  the  absorbance  of  the  stan-
ards.  Linear  SOD,  GSH,  and  MDA  concentrations  were
alculated  according  to  this  equation.  The  results  for  SOD,
SH,  and  MDA  in  the  tissues  were  expressed  as  U/mg  protein,
moL/mL  protein,  and  nmoL/mg  protein,  respectively.  All
ata  are  presented  as  mean  ±  standard  deviation  (SD)  based
n  per  mg  protein.  Protein  concentrations  were  determined
y  the  Lowry  method  using  commercial  protein  standards
w
d
a
l arrow;  macrophages,  orange  arrow;  degenerative  epithelium
Total  protein  kit-TP0300-1KT;  Sigma  Chemical  Co.,  Munich,
ermany).
tatistical  analysis
ll  data  are  expressed  as  group  mean  ±  SD  and  analyzed
sing  SPSS  (IBM  SPSS  Statistics  20.0,  IBM  Corporation,
omers,  NY,  USA).  Kolmogorov--Smirnov  test  was  applied
or  analysis  of  data  distribution.  The  stereological  and
emi-quantitative  histopathological  data  were  analyzed  by
he  nonparametric  Kruskal--Wallis  test  followed  by  the
ann--Whitney  U-test.  The  parametric  test  of  analysis  of
ariance  (ANOVA)  and  LSD  test  for  mean  separation  were
sed  to  analyze  the  biochemical  data.  A  critical  value  for
igniﬁcance  of  p  <  0.05  was  used  throughout  the  study.
esults
istopathological  results
roup  C  (Control)  --  epithelial  structure  was  seen  normal.
o  cilia  loss  was  observed.  Little  inﬂammatory  cell  inﬁltra-
ion  was  evident  in  the  lamina  propria  and  no  edema  was
bserved  (Fig.  1;  Table  1).
Group  S  (Rhinosinusitis  +  saline)  --  prominent  morphologic
hanges  were  evident  in  the  epithelial  cells.  Loss  of  cilia,
ncreased  number  of  goblet  cells  and  lamina  propria  edema
ere  noticeable  in  this  group.  On  the  other  hand,  the  most
egenerative  epithelium  cells  with  eosinophilic  cytoplasms
nd  condensed  nuclei  were  detected  in  this  group.  Vasodi-
atations  in  veins  and  increased  neutrophil  inﬁltrations  in
ARTICLE IN PRESS+Model
The  effect  of  amlodipine  on  rhinosinusitis  5
Table  1  The  statistical  results  of  semi-quantitative  assessment  of  histopathological  changes  of  all  groups.
Groups  N◦ of  subjects  LPE  LC  V  GCN  CD
C  5  0.14  ±  0.07d 0.09  ±  0.11d 0.12  ±  0.04d 1.11  ±  0.10d 0.14  ±  0.05d
S  5  1.12  ±  0.20c 2.90  ±  0.10a 2.85  ±  0.19b 2.94  ±  0.16a 2.91  ±  0.10a
SC  5  2.06  ±  0.16a 0.40  ±  0.09b 1.70  ±  0.27c 1.18  ±  0.18c 1.07  ±  0.06b
SA  5  1.08  ±  0.21b 0.16  ±  0.09c 2.92  ±  0.08a 1.98  ±  0.47b 1.01  ±  0.17c
C, control group; S, rhinosinusitis + saline group; SC, rhinosinusitis + cefazolin group; SA, rhinosinusitis + amlodipine group; LPE, lamina
propria edema; LC, loss of cilia; V, vasodilatation; GCN, goblet cell number; CD, collagen deposition.
The different superscript letters (a, b, c and d) show that the values in the same colon are statistically different from each other
(p < 0.05). Values given in the table are mean ± standard deviation. Used the Kruskal--Wallis range test option and were considered to
be signiﬁcant at p < 0.05 (all groups).
Table  2  The  statistical  results  of  the  numerical  densities
of Polymorphonuclear  Leukocyte  (PMNL)  inﬁltration  in  the
treatment  and  control  groups.
Groups  PMNL  (mean  ±  SD)
C  1.405  ±  0.034d
S  4.105  ±  0.062a
SC  1.796  ±  0.008c
SA  2.514  ±  0.064b
The different superscript letters (a, b, c and d) show that the
values are statistically different from each other (p < 0.05). Val-
ues given in the table are mean ± standard deviation. Used the
Kruskal--Wallis range test option and were considered to be sig-
niﬁcant at p < 0.05 (all groups).
C, control group; S, rhinosinusitis group; SC, rhinosinusi-
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Figure  2  Superoxide  dismutase  (SOD)  activities  of  the  study
groups. All  groups  showed  a  statistical  difference  from  each
other.  Group  S  presented  the  lowest  SOD  activity.  C,  con-
trol group;  S,  sinusitis  group;  SC,  sinusitis  +  cefazolin  group;
SA, sinusitis  +  amlodipine  group.  Used  the  analysis  of  variance
(ANOVA)  and  LSD  tests  and  were  considered  to  be  signiﬁcant  at
p <  0.05  (all  groups).  The  bars  in  the  different  serial  shown  by
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ety  of  America  recommends  amoxicillin-clavulanate  rathertis + cefazolin group; SA, rhinosinusitis + amlodipine group.
lamina  propria  were  distinguished.  Differently  from  other
groups  macrophage  inﬁltrations  were  seen  and  collagen
deposition  was  increased  in  this  group  (Fig.  1;  Table  1).
Group  SC  (Rhinosinusitis  +  cefazolin  sodium)  --  no  ciliary
loss  was  detected.  The  number  of  goblet  cells  and  colla-
gen  deposition  were  less  than  Group  S.  Dilations  of  vessels
were  similar  to  Group  C.  The  most  lamina  propria  edema  was
seen  in  this  group.  Degenerative  epithelium  cells  were  less
than  Group  S.  Differently  from  the  other  groups  increased
connective  tissue  cells  were  prominent  (Fig.  1;  Table  1).
Group  SA  (Rhinosinusitis  +  amlodipine)  --  this  group  was
similar  to  Group  C  than  the  other  experimental  groups.
No  ciliary  loss  was  detected.  The  numbers  of  goblet  cells
were  less  than  Group  S,  collagen  deposition  and  lamina  pro-
pria  edema  were  similar  to  Group  C.  Vasodilatations  was
increased  than  the  other  experimental  groups.  Degenera-
tive  epithelium  cells  were  less  than  the  other  experimental
groups  (Fig.  1;  Table  1).
Stereological  results
Statistical  analysis  revealed  that  there  were  signiﬁcant  dif-
ferences  between  all  groups  (p  <  0.05).  When  the  mean
numerical  densities  of  PMNLs  for  all  groups  compared,  it
was  seen  Group  S  had  the  highest  value.  The  Group  SA  value
followed  Group  S,  while  the  Group  SC  had  similar  value  to
Group  C  (Table  2).
t
l
phe different  letters  (a,  b,  c,  and  d)  are  statistically  different
rom each  other.
iochemical  results
he  activity  of  SOD  and  the  level  of  GSH,  as  well  as  lipid
eroxidation  (MDA)  levels,  were  evaluated  in  all  animals.
he  results  are  shown  in  Figs.  2--4,  respectively.  The  SOD
p  <  0.004)  activity  and  GSH  (p  <  0.003)  levels  were  reduced,
hereas  the  MDA  (p  <  0.003)  levels  were  increased  signiﬁ-
antly  in  all  three-treatment  groups  compared  to  the  control
roup.  Within  the  treatment  groups,  SOD  (p  <  0.004)  and  GSH
p  <  0.003)  levels  were  highest  in  the  SA  group,  followed  by
he  SC  group,  and  were  lowest  in  the  S  group.  MDA  (p  <  0.003)
evels  were  lowest  in  the  SA  group,  followed  by  the  SC  group,
nd  were  highest  in  the  S  group.
iscussion
he  most  commonly  reported  pathogens  in  acute  bacterial
hinosinusitis  are  streptococcus  pneumonia, Haemophilus
nﬂuenzae, Moraxella  catarrhalis, Streptococcus  pyogenes,
nd  Staphylococcus  aureus. The  Infectious  Diseases  Soci-han  amoxicillin  as  ﬁrst  line  treatment  and  doxycycline,
evoﬂoxacin,  and  moxiﬂoxacin  in  patients  allergic  to
enicillin.17 The  emergence  of  bacteria  resistant  to  current
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Figure  3  Glutathione  (GSH)  levels  of  the  study  groups.  All
groups showed  a  statistical  difference  from  each  other.  Group
S presented  the  lowest  GSH  level.  C,  control  group;  S,  sinusitis
group; SC,  sinusitis  +  cefazolin  group;  SA,  sinusitis  +  amlodipine
group.  Used  the  Used  the  analysis  of  variance  (ANOVA)  and
LSD tests  and  were  considered  to  be  signiﬁcant  at  p  <  0.05  (all
groups).  The  bars  in  the  different  serial  shown  by  the  differ-
ent letters  (a,  b,  c,  and  d)  are  statistically  different  from  each
other.
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Figure  4  Malondialdehyde  (MDA)  levels  of  the  study  groups.
All groups  showed  a  statistical  difference  from  each  other.
Group S  presented  the  highest  MDA  level.  C,  control  group;
S, sinusitis  group;  SC,  sinusitis  +  cefazolin  group;  SA,  sinus-
itis +  amlodipine  group.  Used  the  analysis  of  variance  (ANOVA)
and LSD  tests  and  were  considered  to  be  signiﬁcant  at  p  <  0.05
(all groups).  The  bars  in  the  different  serial  shown  by  the  differ-
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sinusitis.  Kassim  et  al.  reported  that  reduced  glutathionent letters  (a,  b,  c,  and  d)  are  statistically  different  from  each
ther.
ntibiotic  therapies  is  a  worldwide  clinical  threat.  It  is  essen-
ial  to  develop  novel  antibacterials  to  modulate  the  drug
tress  response  of  bacteria  and  host  defence  mechanisms.
lthough  our  study  is  representative  of  acute  rhinosinusitis,
issue  protective  and  anti-inﬂammatory  effects  of  AML  may
ave  a  role  in  preventing  the  prolongation  of  the  disease  and
rogression  to  chronic  state.
Medicinal  compounds  used  for  the  therapy  of  non-
nfectious  pathology  and  that  have  antimicrobial  properties
re  called  non-antibiotics.  These  compounds  are  divided
nto  two  classes:  those  with  direct  antibacterial  activ-
ty  are  called  ‘‘antimicrobial  non-antibiotics’’,  while
he  second  group  consists  of  ‘‘helper  compounds’’  and
‘macrophage  modulators’’.18--20 The  most  well-known
on-antibiotic  compounds  are  phenothiazines,21 chlor-
romazine,  thioridazine,22,23 the  anti-inﬂammatory  drug
iclofenac,24 antihistamines  such  as  promethazine  and
l
i
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iphenhydramine,  and  cardiovascular  drugs  such  as  amlodip-
ne,  dobutamine,  lacidipine,  nifedipine,  and  oxyfedrine.25--27
he  exact  mechanism  of  non-antibiotic  action  has  not  been
etermined  but  they  have  been  proposed  to  modify  cell  per-
eability  and  affect  potassium  and  calcium  efﬂux  pumps  in
usceptible  bacteria.  Drug  resistance  also  has  been  reversed
y  addition  of  non-antibiotics  such  as  phenothiazines  and
hlorpromazine  to  an  antibiotic  to  which  the  bacteria  are
nitially  resistant.19
Amlodipine  has  been  reported  to  have  the  most
owerful  antibacterial  activity  among  cardiovascular  non-
ntibiotics.11 In  vitro  studies  also  suggested  that  dihydro-
yridine  calcium  antagonists  act  as  antioxidants  and  reduce
eukocyte-induced  oxidation  of  low  density  lipoproteins.28
ML  also  has  been  suggested  to  improve  endothelial  dysfunc-
ion  in  diabetes  through  antioxidant  and  anti-inﬂammatory
echanisms.29 It  has  been  shown  to  act  synergistically  with
ntibiotics  and  to  have  in  vivo  and  in  vitro  antimicrobial
ctivity  against  several  bacteria.25
In  our  study,  histopathological  examination  showed  that
ML  improved  lamina  propria  edema,  collagen  deposition,
ecreased  ciliary  loss  compared  to  saline  treated  and  cefa-
olin  treated  groups.  Amlodipine  group  showed  reduced
MNL  inﬁltration  and  goblet  cell  number  compared  to  saline
reated  group.  However  in  cefazolin  treated  group,  gob-
et  cell  number  and  PMNL  inﬁltration  was  signiﬁcantly
ower  than  other  treatment  groups.  Amlodipine  also  caused
ncreased  vasodilatation  compared  to  all  groups  that  may
e  attributed  to  the  direct  vasodilatatory  effect  of  the
ompound.  SOD  and  GSH  are  major  components  of  the
ntioxidant  mechanisms  in  tissue  for  combating  ROS.  In
he  present  study,  SOD  and  GSH  levels  were  highest  in  the
ealthy  control  group  followed  by  the  SA,  SC,  and  S  groups.
evels  of  MDA,  which  indicate  tissue  damage  by  lipid  perox-
dation,  were  lowest  in  the  control  group  and  followed  by
he  SA,  SC,  and  S  groups,  in  increasing  order.  In  our  study
ML  better  improved  the  oxidative  status  than  cefazolin
odium.  These  ﬁndings  suggest  that  AML  improved  antiox-
dant  defence  mechanisms  and  reduced  MDA  levels,  thereby
reventing  the  tissue  damage  caused  by  ROS.
Although  host  defence  mechanisms  are  basic  ways  to
lear  pathogenic  microorganisms,  the  severity  of  infectious
isease  needs  to  be  further  controlled  by  additional  pro-
ective  mechanisms  that  limit  the  extent  of  tissue  damage.
his  is  referred  to  as  disease  tolerance,  which  is  a  biologic
henomenon  mainly  based  on  protection  of  self-tissues  from
mmune  attack.  Tissue  damage  control  is  a very  important
omponent  of  host  defence  mechanisms  against  infection  as
his  enforces  the  barrier  function  of  epithelial  cells  to  pre-
ent  pathogen  access  to  host  tissues  and  limits  the  disease
everity  without  interfering  with  pathogen  load.30
The  pathophysiology  of  chronic  sinusitis  has  been  pro-
osed  to  involve  a  dysfunctional  immune  response  that
ccurs  between  the  host  and  environment,  locally  at  the
evel  of  mucosa.  Defects  in  the  mechanical  barrier  and
ncreased  microbial  colonization  lead  to  increased  stimu-
ation  of  the  immune  system  and  increased  inﬂammation.
ome  reports  indicate  an  altered  oxidative  status  in  chronicevel  was  signiﬁcantly  lower  in  severe  cases  of  chronic  sinus-
tis,  but  were  similar  in  mild  cases  and  controls.31 They  found
lso  signiﬁcantly  decreased  level  of  SOD  both  in  mild  and
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The  effect  of  amlodipine  on  rhinosinusitis  
severe  cases  compared  to  control  subjects,  with  a  greater
decrease  in  severe  cases.  A  study  conducted  by  Westerveld
et  al.  reported  a  signiﬁcant  reduction  in  reduced  glutathione
levels  in  mucosal  samples  taken  from  patients  with  chronic
sinusitis  compared  to  healthy  controls,  but  no  informa-
tion  was  provided  regarding  the  severity  of  disease  in  their
study.32 Improvement  in  oxidative  status  of  sinonasal  mucosa
and  decrease  in  inﬂammation  and  tissue  damage  may  poten-
tially  help  to  treat  acute  rhinosinusitis  and  may  prevent
further  progression  of  the  disease  to  chronic  state.
The  exact  mechanism  of  antimicrobial  action  of  AML
remains  to  be  fully  established.  However,  a  reduction  in
the  minimum  inhibitory  concentrations  of  antibiotics  by  its
use  could  make  it  a  beneﬁcial  auxiliary  compound  for  treat-
ment  of  severe  or  recalcitrant  bacterial  infections  of  the
upper  respiratory  tract.  AML  can  improve  antioxidant  status
and  tissue  integrity  and  decrease  inﬂammation  associated
with  bacterial  rhinosinusitis.  This  drug  may  therefore  have
a  potential  role  in  the  treatment  of  rhinosinusitis  by  con-
trolling  tissue  damage  and  limiting  the  severity  of  disease.
The  results  of  the  present  study  indicated  that  AML
improved  SOD  and  GSH  activities  while  decreasing  MDA
level,  thereby  enhancing  the  oxidative  status  and  decreasing
lipid  peroxidation  in  the  sinonasal  mucosa.
Conclusion
This  study  evaluated  the  effect  of  AML  on  inﬂammation
and  oxidative  status  of  sinonasal  mucosa  as  a  single  agent.
The  combination  of  AML  and  antibiotic  may  produce  a  more
dramatic  decrease  in  oxidative  stress  and  inﬂammation  by
acting  synergistically  with  the  antibiotic.  We  believe  that
future  studies  with  different  microorganisms  and  studies
that  investigate  the  effect  of  AML  co-administered  with  an
antibiotic  both  in  acute  and  chronic  rhinosinusitis  models
would  be  beneﬁcial.
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